Cohen & Steers, Inc.
NYSE:CNSAsset Management
+$0.63 today
- Market cap
- $3.45B
- Beta
- 1.23
- P/E (TTM)
- 24.8
- EPS (TTM)
- $3.03
- Dividend yield
- 3.44%
Volume 0.39M
Average 0.32M
CNS Total Liabilities
Everything the company owes to creditors and other parties.
Cohen & Steers, Inc.NYSE: CNS
Total Liabilities · Q2 FY2026 · quarter ended Jun 2026
Total liabilities broadly unchanged from a year ago
Total liabilities stood at $205.61M at the end of Q2 FY2026, down 1.5% from a year earlier and up 9.5% from the prior quarter. Over 3 fiscal years it compounded at +3.9% a year.
Context
- Total liabilities amounted to 22.8% of total assets at the end of Q2 FY2026, down 5.0 pp from a year earlier.
- Total liabilities increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total liabilities keeps falling in the next quarterly balance sheet after a -1.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 276.6M USD
- Year-over-year change
- +16.5%
- 4-year CAGR
- +16.9%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 276.6M | +16.5% |
| FY2024 | 2024-12-31 | 237.46M | -2.6% |
| FY2023 | 2023-12-31 | 243.91M | -1.0% |
| FY2022 | 2022-12-31 | 246.44M | +66.1% |
| FY2021 | 2021-12-31 | 148.36M | — |
Total Liabilities vs competitors
How CNS compares with its peers on the latest reported figures
- CNS's Jun 2026 total liabilities of $205.61M is the 9th highest of the 10 companies compared; the peer median is $2.41B.
- Its year-over-year change of -1.5% is the 8th highest of 10, against a peer median of +5.1%.
- Total liabilities amounts to 22.8% of total assets for CNS, versus a peer median of 54.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $77.6B | +0.1% | -1.3% | 88.8% | |
| Sep 2026 | $6.55B | -15.5% | -4.7% | 56.0% | |
| Jun 2026 | $6.29B | +25.6% | +21.3% | 70.4% | |
| Sep 2026 | $4.4B | -11.9% | +11.4% | 54.8% | |
| Jun 2026 | $2.41B | +13.1% | +13.3% | 51.5% | |
| Sep 2026 | $1.81B | +0.0% | +7.3% | 42.8% | |
| Jun 2026 | $933.3M | +6.7% | +4.0% | 40.1% | |
| Sep 2026 | $929.8M | +5.1% | -1.0% | 61.4% | |
| Jun 2026 | $205.61M | -1.5% | +3.9% | 22.8% | |
| Jun 2026 | $1.03M | +128.5% | +0.8% | 0.1% | |
| Peer median (excluding CNS) | $2.41B | +5.1% | +4.0% | 54.8% | |
Competitors are the stored peer set for CNS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 184.37M | 247.42M | 187.44M | 182.97M | 145.45M |
| Short-term Investments | 23.71M | 15.29M | 78M | 126.95M | 0 |
| Net Receivables | 87.66M | 68.76M | 73.57M | 75.86M | 81.64M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 295.74M | 331.46M | 339M | 385.79M | 227.09M |
| Property, Plant & Equipment (Net) | 30.95M | 145.19M | 169.64M | 167.8M | 162.41M |
| Goodwill | 18.45M | 17.8M | 18.15M | 17.51M | 18.79M |
| Intangible Assets | 1.25M | 1.25M | 1.25M | 1.25M | 1.25M |
| Long-term Investments | 130.94M | 157.67M | 180.97M | 208.42M | 437.27M |
| Tax Assets | 0 | 0 | 0 | 0 | 41.06M |
| Other Non-current Assets | 15.36M | 19.74M | 27.54M | 31.59M | 22.58M |
| Total Non-current Assets | 196.95M | 341.64M | 397.55M | 426.58M | 683.36M |
| Total Assets | 492.69M | 673.38M | 736.55M | 812.37M | 910.45M |
| Account Payables | 10.18M | 8.42M | 10.14M | 8.49M | 8.62M |
| Short-term Debt | 0 | 0 | 0 | 0 | 15.39M |
| Tax Payables | 22.61M | 7.75M | 5.12M | 4.6M | 1.65M |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 0 | (10.59M) |
| Total Current Liabilities | 33.72M | 17.01M | 15.46M | 15.2M | 15.39M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 33.76M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 90.12M | 90.62M | 88.04M | 81.15M | 104.52M |
| Total Non-current Liabilities | 114.64M | 229.43M | 228.45M | 222.27M | 261.21M |
| Total Liabilities | 148.36M | 246.44M | 243.91M | 237.46M | 276.6M |
| Common Stock | 543K | 551K | 558K | 575K | 583K |
| Retained Earnings | (231.97M) | (171.42M) | (158.19M) | (129.34M) | (105.81M) |
| Accumulated OCI | (5.89M) | (10.78M) | (7.71M) | (10.03M) | (4.66M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 89.14M | 89.39M | 111.42M | 63.19M | 71.9M |
| Total Equity | 344.33M | 426.94M | 492.65M | 574.9M | 633.85M |
| Total Debt | 24.53M | 138.81M | 140.41M | 141.12M | 138.33M |
| Net Debt | (159.85M) | (108.61M) | (47.03M) | (41.86M) | (7.13M) |
Cohen & Steers, Inc.
NYSE:CNS
Intrinsic Alpha fair value
Locked
Current Price
$67.04
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.